Medical Equipment/Supplies/Accessories

NURECA

Nureca Ltd.

Caution — weak structure

Early Trend
Stage 2 VCP active Vol compression

Setup readiness

Early Trend

0.0/100
Entry Zone
₹266.7-308.5
Support Level
₹294.1
Resistance
₹368.4
Risk / Reward
4.1 : 1
Risk Distance
4.7% to stop

Reference levels for educational study only. Not a recommendation to buy or sell.

RS
37.0
ADX
18.0
Vol
22.0

Swing Edge Intelligence

Structured setup analysis · research only

Setup status · Weak structure

Trend, relative strength and distribution characteristics suggest limited breakout quality.

Relative strength Weak
Breakout readiness Low
Accumulation Distribution pressure

Bullish factors

  • Moderate distance from 52w high (-31% below).
  • Price remains below intermediate trend support (50DMA).
  • Price remains distant from the pivot — breakout readiness is low.
  • Relative strength remains below leadership thresholds.
  • 5 closes within 1.4% — tight band forming.
  • ATR shrinking 3 consecutive weeks — coil forming.
  • MACD positive and rising — confirmation only (no bonus).
  • Pivot type: flat-top — premium structure.
  • Price compression 0.28x — range contracted to 40% of normal.
  • Distribution pressure visible across recent sessions.

Risk factors

  • Thin liquidity (₹0.3 Cr/day) — slippage risk
  • 6 distribution days recently — institutional selling
  • Heavy overhead supply (74%) — trapped sellers above

Why not 100?

  • RS rank is below elite leadership band (<90)
  • Volume quality is not in top confirmation range yet

Overall view

Broader structure continues to reflect distribution rather than sustained demand. Overall setup quality remains limited despite any localized compression or accumulation cues.

Trade management framework

Research framework only. Use your own risk controls.

  • If price moves +1R, consider reducing downside by moving stop closer to entry.
  • If price reaches around +1.5R to +2R, consider partial profit booking (for example 20-30%).
  • If trend extends beyond +2R, consider trailing below a fast trend reference (for example 21 EMA).
Size this trade

Setup research

NURECA — trend, RS & risk snapshot (not a trade recommendation)

Signal · context · invalidation · risk · skip reasons — research only

D
29/100 Low-quality — likely skip

Why now

Building toward the pivot (23% below)

  • Volume drying up into the base — supply fading
  • Confirmed Stage 2 uptrend

Flagged today

Context & regime

  • Market regime Mixed / range-bound
  • Trend stage Stage 2 — tradable
  • Sector RS Lagging group
  • Relative strength Lagging (RS 37)
  • Trend strength Weak (ADX 18)

What invalidates it

This idea is wrong below ₹294.1 (-24.1% away)

Base / stop support breaks — the swing thesis is wrong below here

  • Stop / base low₹294.1
  • Pivot — failure re-entry below₹307.0

Risk distance

4.7% to stop
1.6× ATR
4.1× R:R
19.4% reward

Risk ≈ ₹14.38/share from entry ₹308.5.

Reasons to skip 4

Disqualifiers that apply even if the score looks good.

  • Thin liquidity (₹0.3 Cr/day) — slippage risk
  • 6 distribution days recently — institutional selling
  • Heavy overhead supply (74%) — trapped sellers above
  • Elevated failure risk (66/100)

NURECA Support & Resistance Levels

Trader brief

What to understand

NURECA Entry, Stop-Loss & Targets

Research heuristic · not a buy/sell call

Low scanner score suggests weak or incomplete structure. Use this page for context, not as a primary trade candidate until the score and trend improve.

Setup quality Weak
Entry readiness Building · 50
AI insights

AI Insights

Generated with AI

These insights are AI-generated to support your research process and should not be treated as investment advice or a recommendation to buy or sell securities.

Sign in to unlock AI Insights

Personalised swing trade analysis powered by Gemini AI

Pattern context 52w · setup · flow

52-week range

Stage-2 ideal band  ·  Early recovery

Setup highlights

Loading…

Pattern signals from the latest scan

Smart money flow

Last 60 sessions · accumulation vs distribution

Loading…
Session flow 60 trading days
OBV trend On-balance volume · same window
·
Accumulation Distribution Neutral
Setup intelligence Overhead · VCP · radar · risk

Overhead supply

Resistance ceiling above current price

Loading…

Chase / failure risk

Honest read on exhaustion & extended moves

Loading…

Base / VCP coil

Depth, contractions & pivot distance

Loading…

Setup quality radar

Shape of the setup in one view

Loading…
Setup metrics Weak

NURECA Technical Analysis & Swing Setup

Grouped structure, momentum and risk from the latest research scan.

Weak
Volume Profile bullish
POC₹236.0
VAH₹268.0
VAL₹211.76
Vol above POC71.0%
Institutional Activity — Distribution
Avg cost basis₹252.92
Acc zone₹212.0–287.0
Accumulation Sessions2
CMF-0.21

Structure

Trend / stage
Stage 2 (Early)
Stage 2
RS rank
37.0
Weak
ADX
18.0
Weak

Momentum

RSI
40.0
Weakening
Volume quality
22.0
Thin
Relative strength
Lagging
Neutral

Risk

Failure risk
66.0
High risk
Distribution
6 day(s)
Distribution
Volatility
6 VCP
Contracting
More scanner fields
Sector RS 0.0%
Base 16w · 33.5%
VCP waves 6x
Vol dry-up Yes
Avg value ₹0.3 Cr
Failure flags Distribution cluster, Overhead supply, RS laggard, Thin liquidity
Peer comparison Sector peers

Sector Peer Comparison

Loading sector peers…

Fetching peer data…
NURECA FAQ Common swing-trading questions

Frequently asked questions about NURECA

Is NURECA a good swing trade right now?

On Swing Edge's swing-setup framework, Nureca Ltd. (NURECA) currently grades D — low-quality — likely skip. Building toward the pivot (23% below). Flagged today. This is educational research, not investment advice.

What are NURECA's support and resistance levels?

For NURECA, near-term support sits around ₹294.1 (the base/stop zone); overhead resistance is around ₹307.0 (the breakout pivot); the next resistance above is ₹368.4. This is educational research, not investment advice.

What is the breakout / pivot level for NURECA?

The breakout pivot for NURECA is around ₹307.0. Price is about 22.8% below the pivot and still building toward it. A breakout is typically confirmed on a close above the pivot with above-average volume. This is educational research, not investment advice.

Is NURECA above its 50-day and 200-day moving averages?

Yes — NURECA is in a confirmed Stage 2 uptrend, trading above its rising 50- and 200-day moving averages, the zone where swing setups tend to work best. This is educational research, not investment advice.

How strong is NURECA versus the market (RS rank)?

NURECA has a relative strength (RS) rank of 37 out of 100 versus the NSE universe, making it lagging the broader market on relative strength. Trend strength (ADX) reads 18, indicating a weak/choppy trend. This is educational research, not investment advice.

What are the entry, stop-loss and target levels for NURECA?

Reference swing levels for NURECA: entry around ₹308.5, stop-loss around ₹294.1, targets at ₹368.4 and ₹456.5. That works out to roughly a 4.1:1 reward-to-risk on the first target. These are reference levels for study only — this is educational research, not investment advice.

Answers are generated from Swing Edge's latest scan data and are for research only — not investment advice.

Prices and day-change figures use the last daily close from scan data dated 2026-06-19 — not live intraday NSE quotes.